Voxeleron looks into ocular disease prognosis
Voxeleron is, like Google’s related company Deepmind, using artificial intelligence to analyse ocular images. Unlike Deepmind, it is employing a targeted approach.
For drug treatment decisions machine learning must be more than a black box
The industry has its work cut out to rebuild trust in the tech following doubts about one pioneer, IBM Watson.
The new league of imaging companies remaking the market
Since becoming a pure-play health tech group Philips has been buying like crazy. Might Siemens Healthineers and GE Healthcare join in?
How machines could mine forgotten data
Drug discovery is getting harder, and some companies are turning to machine learning to look for new targets.
Big pharma piles into machine learning, but what will it get out of it?
Big pharma is using machine learning to improve the drug development process – but can the tech live up to the hype?
Congenica aims to turn data into information
Sequencing data is all well and good, but what does it mean?
Philips uses its intelligence for outcomes-based incomes
Philips prioritises artificial intelligence-based technologies as it seeks to grow its Connected Care and Health Informatics unit
Artificial intelligence is the real thing for pharma and medtech
Advances in computing power and machine learning could drastically change the way drugs are developed and paid for.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.